EVO earnings: next report 2026-08-13, real EPS beat/miss history, analyst consensus Buy, P/E -3.13. Updated 2026-07-23.
Evotec (EVO) Research Hub
Evotec (EVO) trades on NASDAQ, DE in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 1.73 USD (-4.42%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.13, market cap 0.70B. This hub links to the full technical, earnings and options research available for EVO.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, DE |
| Last close | 1.73 USD (-4.42%) |
| 52-week range | 1.72 USD – 2.93 USD |
| Trend regime | Range |
| 14-day RSI | 33.7 (Bearish) |
| Trailing P/E | -3.13 |
| Market cap | 0.70B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for EVO
Covered Call on EVO: how it works, illustrative setup around the real 1.73 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EVO: how it works, illustrative setup around the real 1.73 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EVO: how it works, illustrative setup around the real 1.73 USD price, max profit/loss, breakeven and when to use it. Educational.
EVO technical analysis: range, last 1.73 USD, RSI 33.7, 52w range 1.72 USD–2.93 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is EVO in?
Evotec (EVO) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, DE.
Is EVO in an uptrend or downtrend?
As of 2026-09-11, EVO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EVO's trailing P/E ratio?
EVO's trailing P/E is -3.13, with a market cap of 0.70B. See the earnings research page for full valuation detail.
When does EVO next report earnings?
EVO is next scheduled to report earnings on 2026-08-13, with a consensus EPS estimate of -0.04701 USD.